The rapid microbiology testing market is booming, projected to reach $5.51 billion by 2025 and grow at a CAGR of 9.53% through 2033. Driven by infectious disease prevalence and advancements in technology, this market offers lucrative opportunities for key players like Abbott, BD, and Thermo Fisher. Learn more about market trends, key players, and future growth projections.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.